Antibodies.com expands Cambridge HQ in new growth phase

The new 5,000 sq ft site is five times larger than its previous premises and has been designed to house increased operational capabilities and broaden access to its range of high-quality reagents and products that support accelerated discovery and development of antibody therapeutics.

Antibodies.com has seen a period of sustained growth and rapid increase in demand for its products globally over the past five years, tripling its customer base and now serving over 5,000 research institutions globally.

With a catalogue of over 100,000 products, including primary and secondary antibodies, proteins, and ELISA kits, Antibodies.com serves researchers in over 100 countries.

The new site features advanced laboratory spaces, a modern logistics area to facilitate enhanced inventory management, and expanded research and development capabilities. Enabling streamlined workflows and upgraded infrastructure, the new facilities will further strengthen order fulfilment, delivering reagents to customers, faster.

Antibodies.com has facilities in Cambridge UK, Stockholm in Sweden, and St. Louis in the US. The new UK headquarters are said to provide dynamic and collaborative workspaces with shared meeting areas, informal breakout zones and designated office spaces.

The central Cambridge location offers easy access to local transport options and designated cycle storage to encourage sustainable travel.

Dr Stewart Newlove, CTO and Co-Founder of Antibodies.com, said: “We are proud to take this significant step forward with our new Cambridge headquarters. This move positions us at the centre of the global life sciences community and will enable us to enhance the excellent service our customers have come to expect, scale with global demand, and continue supporting innovation in the discovery and development of antibody therapeutics.”